All posts by The Trauma Pro

Solid organ

Does Trauma Center Level Make A Difference In Treating Solid Organ Injury?

Leave a comment

In the last two posts, I reviewed contrast anomalies in solid organs, specifically the spleen. Today, I’ll be more general and examine a recent paper that compared management and outcomes after the other major solid organ injury, liver, at Level I vs Level II trauma centers.

There are several papers that have detailed overall differences in outcomes, and specifically mortality, at Level I and II centers. Some of these show outcomes that are not quite as good at Level II centers when compared to Level I. On paper, it looks like these two levels should be very similar. Take away research and residents, and maybe a few of the more esoteric capabilities like reimplantation, and aren’t they about the same?

Well, not really. They can be, though. Level I criteria are fairly strict, and the variability between difference Level I centers is not very great. Level II criteria are a bit looser, and this allows more variability. Many Level II centers function very much like a Level I, but a few are only a bit higher functioning than a Level III with a few extra surgical specialists added in.

A paper currently in press used the Michigan Trauma Quality Improvement Program (MTQIP) data from all 29 ACS verified Level I and II centers in the state (wow!). Six years of information was collected, including the usual demographics, outcome data, and management. A total of 538 patients met inclusion criteria, and this was narrowed down to 454 so statistical comparisons of similar patients could be made for Level I vs Level II centers.

Here are the factoids:

  • Mortality was significantly higher in Level II centers compared to Level I (15% vs 9%) and patients were more likely to die in the first two days, suggesting hemorrhage as the cause
  • Patients were more likely to die in the ED at Level II centers, despite a significantly lower Injury Severity Score (ISS)
  • Pneumonia and ARDS were significantly more likely to develop in Level II center patients
  • Level II centers used angiography less often and took patients to the OR more frequently
  • Level II centers admitted fewer patients to the ICU, but ICU admission was associated with significantly decreased mortality
  • Complications were fewer at Level II centers, but they were less likely to rescue patients when they occurred

Bottom line: Level I and II centers are supposed to be roughly the same, at least on paper. But a number of studies have suggested that there are more disparities than we think. Although this paper is a retrospective review, the sheer number of significant differences and its focus on one particular injury makes it more compelling.

So what to do? Tighten up the ACS Orange Book criteria? That’s a slow and deliberate process that won’t help our patients now. The quickest and most effective solution is for all centers to adopt uniform practice guidelines so they all perform like the highly successful Level I programs in the study. There are plenty of them around. If you are not yet using one, I urge you to have a look at the example below. Tweak it to fit your center. And use your PI program to trend the outcomes!

Related post:

Reference: Variability in Management of Blunt Liver Trauma and Contribution of Level of ACS-COT Verification Status on Mortality. J Trauma, in press, Dec 1, 2017.

Complications

Natural History of the Splenic Blush

Leave a comment

In my last post, I described the two types of solid organ “blushes.” I also described my thoughts on the natural history of these findings. Now, a multicenter study on the natural progression of the splenic “blush” has just been published. I found this paper very interesting, because it challenged some of my own existing beliefs. But once I read it, my enthusiasm faded.

The Western Trauma Association sponsored a multicenter (17 Level I and II centers) review of data collected prospectively over an unspecified period of time. Patients were excluded if their injury was older than 24 hours, if they had a previous splenic injury, and if they had any number of diseases or hereditary conditions that might affect the spleen. Strict definitions of nonbleeding and actively bleeding injuries were applied, and detailed information on intervention and outcomes was collected.

Here are the factoids:

  • 200 patients were enrolled from 17 centers, but the paper does not state how long that took
  • 20% were low grade (1 or 2) and 80 % high grade (3-5)
  • 29% had a pseudoaneurysm, and 83% showed extravasation, which means that several patients had both
  • 15% underwent early splenectomy, 59% underwent angiography, and 26% were observed
  • For those with initial angiography, 6% had repeat angio and 7% eventually underwent splenectomy
  • Of those were were initially observed, 9% had delayed angio and 8% underwent splenectomy
  • Based on a read by an expert radiologist, an actively bleeding injury was associated with a 41% splenectomy rate
  • The authors conclude that the majority of patients with spleen injury with pseudoaneurysm or extravasation are managed with angio and embolization and that splenectomy remains a rare event (??)

Bottom line: This paper just doesn’t do it for me. The biggest problem is that it is what I call a “we do it the way we do it” study. It examines how 17 different centers evaluate and treat patients with significant splenic injury. There was no guidance or guideline on how to treat, so they each did it their way. And the number of patients was small.

They don’t tell us anything about the use or effectiveness of angio by grade. Or whether the specific hospitals routinely rely on angio rather than just going to the OR for high grade injuries (typically if angio response times are long).

Unfortunately, this paper gives the appearance of containing a lot of interesting stuff. But a 15% initial splenectomy rate is not a “rare event” in my book. Everything published here is at odds with what I’ve observed over the years for centers with well developed management guidelines and easy access to angio (< 5% splenectomy rate in hemodynamically stable patients with nonoperative management).

My recommendation is to send all stable patients with pseudoaneursym and/or extravasation to angio immediately! Yes, some will have nothing found by the time they get to angio, and you’ll have to come up with a plan at that point. But most have something wrong, and it won’t stop until it’s been plugged up (or your patient bleeds to death, whichever comes first)!

This article has all the right buzzwords: multicenter, prospective data, etc. But it’s already been moved to my recycle bin. 

Related post:

Reference: Natural history of splenic vascular abnormalities after blunt injury: A Western Trauma Association multicenter trial. J Trauma 83(6):999-1005, 2017.

Abdomen

Splenic Vascular Blush

Leave a comment

Contrast blush is always a concern when seen on CT of the abdomen for trauma. It can represent one of two things, and both are bad:

  • Active extravasation of contrast
  • Splenic pseudoaneurysm

These two clinical issues can be distinguished by looking at the location of the contrast and its persistence. A pseudoaneurysm is located within the parenchyma, and the contrast will wash away, so it will not be visible on delayed images. Contrast that extends beyond the parenchyma or persists in delayed views represents active bleeding. In either case, the failure rate of nonoperative management exceeds 80% in adults without additional measures being taken.

Clinically, these patients usually act as if they are losing volume and require additional crystalloid and/or blood transfusion. The natural history in adults is for bleeding to continue or for the pseudoaneurysm to rupture, resulting in a quick trip to the operating room.

If vital signs can be maintained with fluids and blood, a trip to interventional radiology may solve the problem. Selective or nonselective embolization can be carried out and patients with only a few bleeding points can be spared operation. However, if multiple bleeding areas are seen, it is probably better to head to the OR for splenorrhaphy or splenectomy.

The image below shows likely areas of extravasation. They are a bit large to be pseudoaneurysms.

Spleen Blush-CT

Children are different than adults. Extravasation from spleen injuries in prepubescent children frequently stops on its own. Angiography should only be used if the child is failing nonoperative management.

Next post: A new paper looks at the natural history of these lesions.

General

VTE Prophylaxis Before Spine Surgery?

Leave a comment

Many surgeons and surgical subspecialists are nervous about operating on people who are taking anticoagulants. This seems obvious when it involves patients on therapeutic anticoagulation. But it is much less clear when we are talking about lower prophylactic doses.

Spine surgeons are especially reluctant when they are operating around the spinal cord. Yet patients with spine injury are generally at the highest risk for developing venous thromboembolic (VTE) complications like deep venous thrombosis (DVT) or pulmonary embolism (PE). Is this concern warranted?

Surgeons at the Presley Trauma Center in Memphis examined this issue by performing a retrospective review of six years worth of patients who underwent spine stabilization surgery. They specifically looked at administration of any kind of preop prophylactic anticoagulant, and the most feared complications of bleeding complications and postop VTE.

Here are the factoids:

  • A total of 705 patients were reviewed, with roughly half receiving at least one preop prophylactic dose and the other half receiving none
  • There were 447 C-spine, 231 T-spine, and 132 L-spine operations, performed an average of 4 days after admission
  • Overall, bleeding complications occurred in 2.6% and VTE in 2.8%
  • Patients with VTE were more severely injured (ISS 27 vs 18)
  • Those who received at least half of their possible prophylactic doses had a significantly lower PE rate (0.4% vs 2.2%) but no significant difference in DVT or bleeding complications

Bottom line: So what to make of this? It’s a relatively small, retrospective study, and there is no power analysis. Furthermore, this hospital does not perform routine DVT screening, so that component of VTE may be underestimated, rendering the conclusions invalid.

However, the information on bleeding complications is more interesting, since this is much more reliably diagnosed using an eyeball check under the dressing. So maybe we (meaning our neurosurgeons and orthopedic spine surgeons) need to worry less about preop prophylactic VTE drugs. But we still need better research about whether any of this actually makes a dent in VTE and mortality from PE. To be continued.

Reference: Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury. J Trauma 83(6):1108-1113, 2017.